17.5 C
Houston
Sunday, January 24, 2021

Indonesian health workers receive COVID-19 vaccination

JAKARTA, Indonesia (AP) – Indonesia started vaccinating health workers and public servants for COVID-19 on Thursday, a day after President Joko Widodo received the first shot of China’s Sinovac Biotech vaccine.

The Health Ministry is planning to vaccinate more than 1.3 million health workers and 17.4 million public officials in the first stage.

Indonesia, the world’s fourth most populous country, plans to vaccinate two-thirds of its population of about 270 million people – or just over 180 million people.

“The pandemic is still going on and health care workers are the front-liners in caring for COVID-19 patients,” Deputy Health Minister Dante Saksono said.

- Advertisement -

The first 25 health workers to get the jab were employees of Jakarta’s Cipto Mangunkusumo Hospital.

Hospital Director Lies Dina Liastuti said a total of 6,000 will be vaccinated at a rate of 275 a day.

Indonesia’s Food and Drug Authority green-lighted emergency use authorization of the vaccine produced by China’s Sinovac Biotech Ltd., after the country’s highest Islamic body last week said the shot is fit for consumption by Muslims. Indonesia is the world’s most populous Muslim nation.

The Health Ministry expects it will take 15 months for Indonesia to complete the vaccination program, through March 2022.

The rollout comes as Indonesia registered the daily record in COVID-19 infections and fatalities on Wednesday, with 11,278 cases and 306 deaths in the last 24 hours. The country has recorded more than 858,000 infections and over 24,900 deaths in total.

Some scientists warn that not enough data has been published about the effectiveness or safety of the Sinovac vaccine – and there is uncertainty over just how protective it is. It has yet to be tested in tens of thousands of people in the kind of rigorous study considered necessary before being licensed for wide use.

Researchers in Brazil last week had pegged the vaccine as 78% effective at protecting against symptomatic illness – but this week, after a closer look at mild cases, they announced data showing overall, effectiveness is just over 50%.

Copyright © 2021 The Washington Times, LLC.



Washingtontimes

Latest news

Confessions Of A Deprogrammed Trump Supporter

Authored (satirically) by Matthew Ehret via The Strategic Culture Foundation,As many people are aware, CNN recently aired a wonderful interview by former Moonie-turned-cult-deprogrammer Steve...

Amazon claims in-person vote only way to ensure ‘valid, fair’ union election

Amazon is reportedly attempting to prohibit employees at an Alabama warehouse from participating in an upcoming unionization vote with mail-in ballots.What's the background?Because of...

White House Calls a Lid on First Saturday of Administration

78-year-old Joe Biden must be exhausted after destroying tens of thousands of jobs in his first few days in office because he called a...

California Refuses To Disclose COVID-19 Data Used To Drive Lockdowns

California Governor Gavin Newsom (D) promised months ago that the state's COVID-19 policy decisions would be driven by transparent data that would be shared...

Related news